BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7990481)

  • 1. Thyroid cancer treated in Chang Gung Memorial Hospital (northern Taiwan) during the period 1979-1992: clinical presentation, pathological finding, analysis of prognostic variables, and results of treatment.
    Lin JD; Weng HF; Huang MJ; Huang BY; Huang HS; Jeng LB
    J Surg Oncol; 1994 Dec; 57(4):252-9; discussion 259-60. PubMed ID: 7990481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical treatment of papillary and follicular thyroid carcinoma.
    Lin JD; Jeng LB; Chao TC; Weng HF; Huang HS
    Int Surg; 1996; 81(1):61-6. PubMed ID: 8803709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical presentations and treatment for 74 occult thyroid carcinoma. Comparison with nonoccult thyroid carcinoma in Taiwan.
    Lin JD; Chao TC; Weng HF; Huang HS; Ho YS
    Am J Clin Oncol; 1996 Oct; 19(5):504-8. PubMed ID: 8823480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors that predict metastasis of papillary and follicular thyroid cancers in Taiwan.
    Lin JD; Huang HS; Chen SC; Chao TC
    Otolaryngol Head Neck Surg; 1997 Apr; 116(4):475-82. PubMed ID: 9141397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.
    Lin JD; Huang MJ; Juang JH; Chao TC; Huang BY; Chen KW; Chen JY; Li KL; Chen JF; Ho YS
    Thyroid; 1999 Dec; 9(12):1227-35. PubMed ID: 10646663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follicular thyroid carcinomas with lung metastases: a 23-year retrospective study.
    Lin JD; Chao TC; Hsueh C
    Endocr J; 2004 Apr; 51(2):219-25. PubMed ID: 15118274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors for differentiated thyroid carcinoma and review of the literature.
    Zhao Y; Zhang Y; Liu XJ; Shi BY
    Tumori; 2012; 98(2):233-7. PubMed ID: 22677990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the clinical characteristics of patients with papillary thyroid carcinoma in Taiwan.
    Lin JD; Chao TC; Sun JH; Ho C; Weng HF
    Oncology; 2000 May; 58(4):280-5. PubMed ID: 10838492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early recurrence of papillary and follicular thyroid carcinoma predicts a worse outcome.
    Lin JD; Hsueh C; Chao TC
    Thyroid; 2009 Oct; 19(10):1053-9. PubMed ID: 19772423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of postoperative serum thyroglobulin levels in patients with papillary and follicular thyroid carcinomas.
    Lin JD; Huang MJ; Hsu BR; Chao TC; Hsueh C; Liu FH; Liou MJ; Weng HF
    J Surg Oncol; 2002 May; 80(1):45-51. PubMed ID: 11967907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifactorial analysis of survival and recurrences in differentiated thyroid cancer. Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.
    Rodríguez-Cuevas S; Labastida-Almendaro S; Cortés-Arroyo H; López-Garza J; Barroso-Bravo S
    J Exp Clin Cancer Res; 2002 Mar; 21(1):79-86. PubMed ID: 12071534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and therapy of differentiated thyroid gland carcinomas].
    Mann K
    Internist (Berl); 2002 Feb; 43(2):174-85. PubMed ID: 11963755
    [No Abstract]   [Full Text] [Related]  

  • 14. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group.
    Hölzer S; Reiners C; Mann K; Bamberg M; Rothmund M; Dudeck J; Stewart AK; Hundahl SA
    Cancer; 2000 Jul; 89(1):192-201. PubMed ID: 10897018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Differentiated Thyroid Carcinoma of Follicular Cell Origin: Prognostic Significance of Histologic Subtypes.
    Balachandar S; La Quaglia M; Tuttle RM; Heller G; Ghossein RA; Sklar CA
    Thyroid; 2016 Feb; 26(2):219-26. PubMed ID: 26854950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer.
    Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z
    Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis.
    Sampson E; Brierley JD; Le LW; Rotstein L; Tsang RW
    Cancer; 2007 Oct; 110(7):1451-6. PubMed ID: 17705176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison with published systems of a new staging system for papillary and follicular thyroid carcinoma.
    Wong RM; Bresee C; Braunstein GD
    Thyroid; 2013 May; 23(5):566-74. PubMed ID: 23106409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification of 282 differentiated thyroid cancers found incidentally in 1369 total thyroidectomies according to the 2015 ATA guidelines; implications for management and treatment.
    Christakis I; Dimas S; Kafetzis ID; Roukounakis N
    Ann R Coll Surg Engl; 2018 May; 100(5):357-365. PubMed ID: 29484944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador.
    Solis-Pazmino P; Salazar-Vega J; Lincango-Naranjo E; Garcia C; Koupermann GJ; Ortiz-Prado E; Ledesma T; Rojas T; Alvarado-Mafla B; Carcamo C; Ponce OJ; Brito JP
    BMC Cancer; 2021 Jan; 21(1):42. PubMed ID: 33419403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.